Question 1

How is the edrophonium test used to diagnose myasthenia gravis?

Accepted Answer

The edrophonium test diagnoses myasthenia gravis by administering a short-acting cholinesterase inhibitor intravenously. A 2 mg dose of edrophonium chloride is injected first; if no effect occurs within 45 seconds, an additional 8 mg is given. Significant improvement in muscle strength lasting about 5 minutes indicates a positive diagnosis for myasthenia gravis.

Question 2

What causes muscle weakness in myasthenia gravis?

Accepted Answer

Myasthenia gravis causes skeletal muscle weakness and paralysis due to impaired neuromuscular transmission. The condition is autoimmune, involving anti-receptor antibodies against nicotinic acetylcholine receptors that disrupt normal signal transmission between nerves and muscles. These antibodies prevent proper muscle contraction and receptor activation.

Question 3

How do antibody tests confirm myasthenia gravis diagnosis?

Accepted Answer

Detecting anti-receptor antibodies against nicotinic acetylcholine receptors in plasma or muscle biopsies confirms myasthenia gravis diagnosis. These antibodies disrupt receptor function and are prevalent in most myasthenia patients. Identifying their presence provides direct evidence of the autoimmune mechanism underlying the disease.

Question 4

What role does electromyography play in diagnosing myasthenia gravis?

Accepted Answer

Electromyography and repetitive nerve stimulation assess muscle activity and confirm myasthenia gravis diagnosis through electrodiagnostic studies. These tests evaluate nerve conduction and muscle contraction, revealing the characteristic impairment of neuromuscular transmission. They help distinguish myasthenia from other muscular dystrophies and confirm diagnosis.

Question 5

Why are imaging tests important in myasthenia gravis evaluation?

Accepted Answer

Imaging tests such as MRI or CT scans help identify thymus gland tumors, which frequently accompany myasthenia gravis and play a significant role in disease pathology. Detecting thymus abnormalities is crucial because thymus involvement affects treatment decisions and patient outcomes in myasthenia gravis management.

Question 6

What initial diagnostic approach is used for suspected myasthenia gravis?

Accepted Answer

Initial diagnosis of myasthenia gravis is based on symptoms exhibited and the patient's medical history. Clinicians look for characteristic signs of skeletal muscle weakness and assess the patient's clinical presentation. This clinical evaluation guides the selection of confirmatory diagnostic tests including the edrophonium test and antibody detection.

Question 7

How do anticholinesterase inhibitors improve symptoms in myasthenia gravis?

Accepted Answer

Anticholinesterase inhibitors like edrophonium block acetylcholinesterase enzyme, allowing acetylcholine to accumulate at the neuromuscular junction. This increased acetylcholine concentration compensates for impaired receptor function, producing significant symptom improvement. The short-term improvement after edrophonium administration serves as both a diagnostic indicator and therapeutic demonstration.

מיאסטניה גרביס: בדיקות אבחון

Browse More Videos